$CDZI
CADIZ INC

2023 Q3 Form 10-Q Financial Statement

#000143774923023100 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $368.0K $809.0K $574.0K
YoY Change -38.56% 337.3% 304.23%
Cost Of Revenue $692.0K $768.0K $904.0K
YoY Change -40.5%
Gross Profit -$324.0K $41.00K -$330.0K
YoY Change -42.55% -77.84%
Gross Profit Margin -88.04% 5.07% -57.49%
Selling, General & Admin $5.130M $5.320M $4.431M
YoY Change 36.07% 56.24% 15.3%
% of Gross Profit 12975.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $310.0K $305.0K $181.0K
YoY Change 72.22% 77.33% 64.55%
% of Gross Profit 743.9%
Operating Expenses $5.440M $5.625M $4.612M
YoY Change 40.21% 57.25% 16.67%
Operating Profit -$5.759M -$5.584M -$4.942M
YoY Change 29.59% 64.62%
Interest Expense $1.173M $1.338M -$2.119M
YoY Change -44.06% -34.89% 6.7%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.932M -$7.062M -$7.061M
YoY Change 5.98% 29.65% 21.8%
Income Tax $4.000K $2.000K $2.000K
% Of Pretax Income
Net Earnings -$6.936M -$7.064M -$8.140M
YoY Change 5.97% 28.83% 37.87%
Net Earnings / Revenue -1884.78% -873.18% -1418.12%
Basic Earnings Per Share -$0.12 -$0.13
Diluted Earnings Per Share -$0.12 -$0.13 -$0.15
COMMON SHARES
Basic Shares Outstanding 66.60M 66.60M 55.82M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.30M $19.24M $9.997M
YoY Change 91.17% 45.31% -8.83%
Cash & Equivalents $13.31M $19.24M $9.997M
Short-Term Investments
Other Short-Term Assets $800.0K $1.901M $1.984M
YoY Change -61.52% -13.51% 0.25%
Inventory $2.128M $1.165M $316.0K
Prepaid Expenses
Receivables $410.0K $880.0K $454.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.63M $23.18M $12.44M
YoY Change 67.65% 48.69% -5.9%
LONG-TERM ASSETS
Property, Plant & Equipment $85.54M $85.44M $84.14M
YoY Change 5.9% 6.12% 6.65%
Goodwill $5.714M $5.714M $5.700M
YoY Change 49.86% 49.86% 49.49%
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $5.562M $5.473M $5.030M
YoY Change 23.33% 20.6% 17.09%
Total Long-Term Assets $97.83M $97.67M $98.35M
YoY Change 3.85% -0.84% -0.93%
TOTAL ASSETS
Total Short-Term Assets $16.63M $23.18M $12.44M
Total Long-Term Assets $97.83M $97.67M $98.35M
Total Assets $114.5M $120.9M $110.8M
YoY Change 9.92% 5.92% -1.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.626M $1.163M $1.107M
YoY Change 251.95% 83.73% 287.06%
Accrued Expenses $1.184M $1.623M $1.545M
YoY Change 30.54% 2.59% 91.21%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $193.0K $128.0K $140.0K
YoY Change 30.41% 124.56% 30.84%
Total Short-Term Liabilities $5.930M $5.768M $5.639M
YoY Change 113.16% 60.85% 124.39%
LONG-TERM LIABILITIES
Long-Term Debt $37.39M $36.92M $48.95M
YoY Change -22.66% -22.44% 5.32%
Other Long-Term Liabilities $39.00K $38.00K $36.00K
YoY Change 11.43% 11.76% 12.5%
Total Long-Term Liabilities $37.43M $36.96M $48.99M
YoY Change -22.64% -22.41% 5.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.930M $5.768M $5.639M
Total Long-Term Liabilities $37.43M $36.96M $48.99M
Total Liabilities $66.80M $68.22M $76.56M
YoY Change -7.46% -8.84% 6.51%
SHAREHOLDERS EQUITY
Retained Earnings -$631.8M -$623.6M -$603.3M
YoY Change 6.16% 6.17% 5.21%
Common Stock $664.0K $664.0K $556.0K
YoY Change 31.23% 31.23% 27.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $47.66M $52.63M $34.22M
YoY Change
Total Liabilities & Shareholders Equity $114.5M $120.9M $110.8M
YoY Change 9.92% 5.92% -1.52%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$6.936M -$7.064M -$8.140M
YoY Change 5.97% 28.83% 37.87%
Depreciation, Depletion And Amortization $310.0K $305.0K $181.0K
YoY Change 72.22% 77.33% 64.55%
Cash From Operating Activities -$5.530M -$5.802M -$5.225M
YoY Change -5.05% 34.06% -7.21%
INVESTING ACTIVITIES
Capital Expenditures $610.0K $1.007M $944.0K
YoY Change -189.18% -182.68% -152.04%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$645.0K
YoY Change -100.0% 400.0%
Cash From Investing Activities -$610.0K -$1.007M -$1.589M
YoY Change -10.95% -17.32% -18.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.080M -1.306M 8.589M
YoY Change 1.79% 0.54% -678.38%
NET CHANGE
Cash From Operating Activities -5.530M -5.802M -5.225M
Cash From Investing Activities -610.0K -1.007M -1.589M
Cash From Financing Activities -1.080M -1.306M 8.589M
Net Change In Cash -7.220M -8.115M 1.775M
YoY Change -4.62% 18.55% -119.59%
FREE CASH FLOW
Cash From Operating Activities -$5.530M -$5.802M -$5.225M
Capital Expenditures $610.0K $1.007M $944.0K
Free Cash Flow -$6.140M -$6.809M -$6.169M
YoY Change 19.46% 118.94% 61.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3392000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
2055000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5447000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-35000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5483000 usd
CY2022Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1288000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6771000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Operating Income Loss
OperatingIncomeLoss
-7176000 usd
us-gaap Interest Expense
InterestExpense
4047000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11223000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-169000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11395000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2553000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13948000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
329
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
329
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
329
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
329
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
85000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66595606
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66595606
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55823810
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55823810
CY2023Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
550
CY2023Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2023Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
560
CY2022Q1 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2022Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
550
CY2022Q2 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.08875 pure
CY2022Q2 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
560
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66595606
CY2013Q1 cdzi Number Of Milestones For Common Stock Issuance
NumberOfMilestonesForCommonStockIssuance
2 pure
CY2013Q1 cdzi Shares Payable Term From Date Earned
SharesPayableTermFromDateEarned
P3Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-12114
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0313235
dei Entity Address Address Line1
EntityAddressAddressLine1
550 South Hope Street, Suite 2850
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90071
dei City Area Code
CityAreaCode
213
dei Local Phone Number
LocalPhoneNumber
271-1600
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
66595606
CY2023Q2 us-gaap Revenues
Revenues
809000 usd
CY2022Q2 us-gaap Revenues
Revenues
185000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
768000 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5320000 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3405000 usd
CY2023Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
305000 usd
CY2022Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
172000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
6393000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
3577000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5584000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
1338000 usd
CY2023Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
210000 usd
CY2022Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
CY2023Q2 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
350000 usd
CY2022Q2 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
-0 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7062000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7064000 usd
CY2023Q2 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1288000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8352000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
66606000
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
50770000
us-gaap Revenues
Revenues
939000 usd
us-gaap Revenues
Revenues
328000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
790000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9251000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7211000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
634000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
293000 usd
us-gaap Costs And Expenses
CostsAndExpenses
10675000 usd
us-gaap Costs And Expenses
CostsAndExpenses
7504000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9736000 usd
us-gaap Interest Expense
InterestExpense
2842000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
378000 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
0 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
220000 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
-0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5331000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-17751000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-17755000 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2553000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20308000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
64633000
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
47619000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19237000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9997000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
880000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
454000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
1165000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
316000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
613000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
380000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
23183000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
12435000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85439000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84138000 usd
CY2023Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 usd
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
420000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
5714000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5714000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
494000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2497000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5473000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5030000 usd
CY2023Q2 us-gaap Assets
Assets
120857000 usd
CY2022Q4 us-gaap Assets
Assets
110787000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1163000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1107000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1623000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1545000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
128000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
140000 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
1288000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
1288000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1450000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1450000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
116000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5768000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5639000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36924000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
48950000 usd
CY2023Q2 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
21789000 usd
CY2022Q4 cdzi Lessor Operating Lease Deposit Liabilities
LessorOperatingLeaseDepositLiabilities
20745000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2570000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
384000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
444000 usd
CY2023Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
38000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
36000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
68223000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
76564000 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
664000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
556000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
675574000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
636963000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-623606000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-603298000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
52634000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34223000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120857000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110787000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17755000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11395000 usd
us-gaap Depreciation
Depreciation
634000 usd
us-gaap Depreciation
Depreciation
293000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
273000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1160000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
59000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
12000 usd
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
435000 usd
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
0 usd
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
1032000 usd
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
913000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
220000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-5331000 usd
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-0 usd
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
0 usd
cdzi Income Loss From Equity Method Investments Excluding Investing Activities
IncomeLossFromEquityMethodInvestmentsExcludingInvestingActivities
169000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
489000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
856000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
426000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-116000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
849000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
344000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
233000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-125000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
443000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
242000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
816000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
216000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-53000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-172000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
599000 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
743000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9871000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7550000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3213000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1748000 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-0 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3213000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1848000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
38490000 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
11741000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
2553000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
2553000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15088000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
69000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
27000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
600000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
-0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
261000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
-0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19961000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9119000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6877000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-279000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13782000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19856000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20659000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19577000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34223000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
65000 usd
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38490000 usd
CY2023Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1265000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10691000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
60822000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
164000 usd
CY2023Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1288000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-7064000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
52634000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
40609000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
433000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11741000 usd
CY2022Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1265000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5912000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
45606000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
423000 usd
CY2022Q2 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
1288000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5483000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
39258000 usd
us-gaap Net Income Loss
NetIncomeLoss
-17800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-11400000 usd
CY2023Q2 cdzi Working Capital
WorkingCapital
17400000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9900000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5300000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15000000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19237000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9997000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13239000 usd
CY2023Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1288000 usd
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
134000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2497000 usd
CY2022Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5050000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
20659000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13782000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19577000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q2 us-gaap Revenues
Revenues
809000 usd
CY2023Q2 us-gaap Revenues
Revenues
809000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
768000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5320000 usd
CY2023Q2 us-gaap Depreciation Nonproduction
DepreciationNonproduction
305000 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
6393000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5584000 usd
us-gaap Revenues
Revenues
939000 usd
us-gaap Revenues
Revenues
939000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
790000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9251000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
634000 usd
us-gaap Costs And Expenses
CostsAndExpenses
10675000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9736000 usd
CY2023Q2 us-gaap Assets
Assets
120857000 usd
CY2022Q4 us-gaap Assets
Assets
110787000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
5714000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
5714000 usd
CY2021Q2 cdzi Water Supply Agreement Number Of Acrefeet Of Water Per Annum To Customer
WaterSupplyAgreementNumberOfAcrefeetOfWaterPerAnnumToCustomer
9500 pure
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
489000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
856000 usd
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5029000
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1533000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5029000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1533000
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1450000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
2350000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
130000 usd
CY2023Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3670000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-350000 usd
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
4020000 usd
CY2023Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
17500000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
17500000 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
1450000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2570000 usd
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4020000 usd
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
85000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66595606
CY2013Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
400000
CY2013Q1 cdzi Percentage Of Projects Annual Capacity
PercentageOfProjectsAnnualCapacity
0.51 pure
us-gaap Payments Of Dividends
PaymentsOfDividends
9108000 usd

Files In Submission

Name View Source Status
0001437749-23-023100-index-headers.html Edgar Link pending
0001437749-23-023100-index.html Edgar Link pending
0001437749-23-023100.txt Edgar Link pending
0001437749-23-023100-xbrl.zip Edgar Link pending
cdzi-20230630.xsd Edgar Link pending
cdzi-20230630_cal.xml Edgar Link unprocessable
cdzi20230630_10q.htm Edgar Link pending
ex_558186.htm Edgar Link pending
ex_558215.htm Edgar Link pending
ex_558216.htm Edgar Link pending
ex_558217.htm Edgar Link pending
ex_558218.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image1.jpg Edgar Link pending
image10.jpg Edgar Link pending
image11.jpg Edgar Link pending
image12.jpg Edgar Link pending
image13.jpg Edgar Link pending
image14.jpg Edgar Link pending
image15.jpg Edgar Link pending
image16.jpg Edgar Link pending
image2.jpg Edgar Link pending
image3.jpg Edgar Link pending
image4.jpg Edgar Link pending
image5.jpg Edgar Link pending
image6.jpg Edgar Link pending
image7.jpg Edgar Link pending
image8.jpg Edgar Link pending
image9.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
cdzi-20230630_pre.xml Edgar Link unprocessable
cdzi20230630_10q_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cdzi-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cdzi-20230630_lab.xml Edgar Link unprocessable